Johnson & Johnson*, a global leader in eye health, announced new data on the ACUVUE OASYS MAX 1-Day for ASTIGMATISM contact lenses which showed higher end-of-day comfort^ as compared to Dailies ...
A novel device for virtual IOL implantation may help ophthalmologists compare the visual performance of a monofocal IOL vs. a ...
Craig See, MD, a cornea specialist for the Cole Eye Institute at Cleveland Clinic, emphasized taking proper safety ...
My comment section is filled with people who doubt my blindness simply for the reason that it appears I’m looking at the ...
ClearSight has established itself as a provider of vision correction services by offering patients advanced all-laser LASIK procedures designed to improve clarity and reduce dependence on glasses and ...
Around age 40, most adults notice the need to hold a phone or book a little farther away to read. Vision changes, which happen to almost everyone during midlife, may feel like another sign of aging, ...
Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...
Q3 2025 Earnings Call Transcript October 14, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, ...
Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world evidence and long-term data reinforce VYVGART’s sustained ...
Dispensing optician and AOP member, James Dawson, shares advice on dispensing early presbyopes as first-time spectacle ...